Mo Shen

728 citations
44 papers · 397 indexed · h-index 13

Impact in

Papers in

Mo Shen

33 papers receiving 393 citations

Peers

Mo Shen
Comparison fields: 5 of 96
  • Cancer Research 94
  • Molecular Medicine 21
  • Reproductive Medicine 25
  • Molecular Biology 186
  • Immunology 55
Replace Kazuaki Nomura with:
Kazuaki Nomura Japan
Yuqi Zhou China
Chris Hsu United States
Mai Hong Bang Vietnam
Zhijun Zhang China
Desheng Fan China
Mahmoud A. F. Khalil Egypt
Rong Geng China
Tomoyuki Otani Japan
Ke Wei China
Mo Shen relative to Kazuaki Nomura Japan Kazuaki Nomura's profile →
Citations per field
00.5×
Kazuaki Nomura · 1×
Citations per year

Countries citing papers authored by Mo Shen

Since Specialization
Citations

This map shows the geographic impact of Mo Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Shen more than expected).

Fields of papers citing papers by Mo Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Shen. The network helps show where Mo Shen may publish in the future.

Co-authors

The 25 scholars most cited alongside Mo Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mo Shen Line = papers co-authored together Mo Shen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201133
2 201330
3 201828
4 201526
5 201025
6 202223
7 202120
8 202220
9 202118
10 201115
11 201015
12 202115
13 201615
14 201412
15 201411
16 202311
17 202011
18 20229
19 20219
20 20237

About Mo Shen

Mo Shen is a scholar working on Molecular Medicine, Microbiology, Applied Microbiology and Biotechnology, Clinical Biochemistry and Cancer Research, having authored 44 papers that have together received 397 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Bacterial biofilms and quorum sensing (5 papers), Lung Cancer Treatments and Mutations (5 papers), Prostate Cancer Treatment and Research (4 papers), Antimicrobial Peptides and Activities (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Lung Cancer Research Studies (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Cancer Research (94 citations), Molecular Medicine (21 citations), Reproductive Medicine (25 citations), Molecular Biology (186 citations) and Immunology (55 citations). Mo Shen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiuling Wu, Xiang Wang, Huihui Guo, Zhanguo Chen, Wu Zhou, Tieli Zhou, Lingbo Wang, Dongqing Lv, Zhihua Tao and Yao Sun. Their work appears in journals such as Frontiers in Oncology, Experimental and Molecular Pathology, Frontiers in Microbiology, Physica C Superconductivity and Immunology Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026